- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
John C. Richter
News 14 results
In the News · Source: Mealey's Daily News Update - Insurance and Mealey's Daily News Update - PI/Product Liability
March 7, 2023
Erich Almonte, John Richter, Jeremy Bylund and David Mattern advise Senseonics in a qui tam case before a Texas federal court
In the News · Source: NAFUSA
June 29, 2022
The National Association of Former United States Attorneys board elects John Richter as president
In the News · Source: The New York Times
April 8, 2022
Tom Spulak, John Richter and William McClintock represent a steel producer in a Federal Election Commission enforcement action
Events 11 results
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Insights 24 results
Article · Source: U.S. Chamber of Commerce Litigation Center Blog
October 13, 2022
Top False Claims Act Developments
Client Alert
May 16, 2022
Cooperation Credit and Attorney-Client Privilege: The Implications of Coburn
Article
October 27, 2021
Congress Can Do Better Against Fraud
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry